Product: Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341.  NDC:  84139-209-03
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20251015
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated